Center for Health Decision Science (CHDS)

ctrdecisionscience.bsky.social

17 September 2026 15:33

CHDS faculty @ankurfactorial.bsky.social & affiliate @jinyizhu.bsky.social discussed the cost-effectiveness of using apolipoprotein B, non–high-density lipoprotein cholesterol, or low-density lipoprotein cholesterol goals to guide statin intensification in a JAMA opinion editorial. shorturl.at/1bDWD

Center for Health Decision Science (CHDS)

ctrdecisionscience.bsky.social

08 September 2026 13:09

CHDS' Lisa Robinson (@lisa-a-robinson.bsky.social) was featured in the recent Risk Analysis profile that highlighted her more than 40-year career focused on benefit-cost analysis and economic evaluation. shorturl.at/UAWlj @sbcasociety.bsky.social @oecd-ocde.bsky.social y.social

Dominik Mockus

domininkasm.bsky.social

29 August 2026 13:02

Moderator @carolinececot.bsky.social will be joined by Cary Coglianese, Don Kenkel, Cathy Kling, Josh Linn, and @lisa-a-robinson.bsky.social. We hope to see you there!

Harvard Chan C-CHANGE

harvardcchange.bsky.social

29 August 2026 13:01

EPA says it will no longer quantify the health benefits of reduced air pollution. Our core faculty member @lisa-a-robinson.bsky.social explains what that means and why it matters: buff.ly/1eEJsaW via @harvardsalata.bsky.social

R. Daniel (Danny) Bressler

rdbressler.bsky.social

29 August 2026 13:01

The best, clearest article I've read yet on recent regulatory changes. The crucial bigger picture, that I agree has been overlooked, is that the health benefits from regulations are no longer being quantified. Lives are being valued at zero de facto because they are being ignored.